Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC100289058 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
PDE11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LINC00659 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SCUBE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADRA2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LNX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506489 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF503-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929622 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FUT7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LPP-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACTR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTSE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01140 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HLF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on